Prophylactic Anticoagulation in Nephrotic Syndrome

Overview

Journal Kidney360

Specialty Nephrology

Date 2023 Aug 1

PMID 37526679

Authors

Jonathon Gerstein

Kiran Battu

Heather N Reich

Affiliations

Soon will be listed here.

References

Barbour S, Greenwald A, Djurdjev O, Levin A, Hladunewich M, Nachman P . Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2011; 81(2):190-5. DOI: 10.1038/ki.2011.312. View

Mahady S, Polekhina G, Woods R, Wolfe R, Wetmore J, Margolis K . Association Between CKD and Major Hemorrhage in Older Persons: Data From the Aspirin in Reducing Events in the Elderly Randomized Trial. Kidney Int Rep. 2023; 8(4):737-745. PMC: 10105042. DOI: 10.1016/j.ekir.2023.01.012. View

Makani A, Saba S, Jain S, Bhonsale A, Sharbaugh M, Thoma F . Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Patients With Chronic Kidney Disease and Atrial Fibrillation. Am J Cardiol. 2019; 125(2):210-214. DOI: 10.1016/j.amjcard.2019.10.033. View

Lam E, Bashir B, Chaballa M, Kraft W . Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy. Expert Rev Clin Pharmacol. 2019; 12(8):781-790. PMC: 6656586. DOI: 10.1080/17512433.2019.1637733. View

Derebail V, Zhu J, Crawford M, Garnier J, Martin K, Skinner S . Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial. Am J Kidney Dis. 2022; 81(3):373-376. DOI: 10.1053/j.ajkd.2022.09.011. View

Kawai M, Harada M, Motoike Y, Koshikawa M, Ichikawa T, Watanabe E . Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study. Int J Cardiol Heart Vasc. 2019; 22:111-116. PMC: 6348981. DOI: 10.1016/j.ijcha.2019.01.002. View

Mahmoodi B, ten Kate M, Waanders F, Veeger N, Brouwer J, Vogt L . High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2007; 117(2):224-30. DOI: 10.1161/CIRCULATIONAHA.107.716951. View

Akoglu H, Agbaht K, Piskinpasa S, Falay M, Dede F, Ozet G . High frequency of aspirin resistance in patients with nephrotic syndrome. Nephrol Dial Transplant. 2011; 27(4):1460-6. DOI: 10.1093/ndt/gfr476. View

Fang M, Go A, Chang Y, Borowsky L, Pomernacki N, Udaltsova N . A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011; 58(4):395-401. PMC: 3175766. DOI: 10.1016/j.jacc.2011.03.031. View

10.

Canney M, Gunning H, Zheng Y, Rose C, Jauhal A, Hur S . The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases. Am J Kidney Dis. 2022; 80(6):740-750. DOI: 10.1053/j.ajkd.2022.04.005. View

11.

Lionaki S, Derebail V, Hogan S, Barbour S, Lee T, Hladunewich M . Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2011; 7(1):43-51. PMC: 3265338. DOI: 10.2215/CJN.04250511. View